A Phase 2, Open-label, Single-arm, Two-cohort Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Relapsed/Refractory Primary Testicular Lymphoma (PTL)

Sponsor
Bristol-Myers Squibb

Protocol Number
Bristol-Myers Squibb CA209-647

To Learn More Call
201-510-0910